Novo Nordisk Inc., FDA approves Novo Nordisks Wegovy pill, the first and only oral GLP-1 for weight loss in adults (2025).
Reactions to Watch For While rare, some individuals may experience adverse reactions to semaglutide
GIP appears to work synergistically with GLP 1 to reduce the gastrointestinal side effects that often limit GLP 1 medication tolerance
Retrieved August 19, 2025, from National Center for Biotechnology Information website
For instance, vitamin B12 supports the nervous system, while vitamin D affects mood functions in the brain
What sets TRIUMPH-4 apart from early testing on drugs like Ozempic, Wegovy, Mounjaro and Zepbound is that participants were diabetes-free